HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ProMune (CpG 7909)

an anticancer adjuvant and immunostimulant
Also Known As:
CpG 7909; CpG 2006; CpG 7907; CpG 8916; CpG 8954; CpG-7907; CpG-7909; CpG-8916; CpG-8954; CpG7907; CpG7909; CpG8916; CpG8954; PF 3512676; PF-3512676; PF03512676; PF3512676
Networked: 59 relevant articles (8 outcomes, 29 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Krieg, Arthur M: 10 articles (04/2012 - 08/2003)
2. Ellis, Ruth D: 6 articles (12/2014 - 08/2008)
3. Miura, Kazutoyo: 6 articles (12/2014 - 08/2008)
4. Long, Carole A: 5 articles (12/2014 - 07/2007)
5. Link, Brian K: 5 articles (07/2013 - 09/2006)
6. Fay, Michael P: 5 articles (01/2012 - 08/2008)
7. Mullen, Gregory E D: 5 articles (01/2010 - 07/2007)
8. Zhu, Daming: 4 articles (12/2014 - 08/2008)
9. Weiner, George J: 4 articles (07/2013 - 09/2006)
10. Martin, Laura B: 4 articles (01/2012 - 06/2009)

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Neoplasms (Cancer)
3. Renal Cell Carcinoma (Grawitz Tumor)
4. Anthrax
5. Tuberculosis (Tuberculoses)

Related Drugs and Biologics

1. Oligodeoxyribonucleotides
2. Toll-Like Receptors (Toll-Like Receptor)
3. Vaccines
4. Toll-Like Receptor 9
5. Paclitaxel (Taxol)
6. Carboplatin (JM8)
7. Proteins (Proteins, Gene)
8. Platinum
9. Cisplatin (Platino)
10. Gemcitabine

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Radioimmunotherapy
4. Subcutaneous Injections
5. Intradermal Injections